Frequency of Laboratory Monitoring During ART
- Clinicians should screen patients for asymptomatic adverse events associated with antiretroviral therapy (ART) as detailed in Table 1: Minimum Laboratory Monitoring Frequency With Initiation of or Change in ART for Patients <50 Years Old and Without Chronic Comorbidities. (A3)
- Recommendations in Table 1 represent the minimum frequency of monitoring in healthy patients receiving ART. Patients with comorbidities, polypharmacy, baseline laboratory abnormalities, or symptoms suggestive of antiretroviral toxicity may require more frequent testing. (A3)
